Natixis Advisors, L.P. Maravai Lifesciences Holdings, Inc. Transaction History

Natixis Advisors, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.14 - $12.85 $235,291 - $330,797	25,743 Added 6.64%	413,417 $4.13 Million
Q2 2023 Aug 15, 2023	SELL	$12.09 - $15.0 $3.06 Million - $3.79 Million	-252,758 Reduced 39.47%	387,674 $4.82 Million
Q1 2023 May 11, 2023	BUY	$12.99 - $16.48 $2.2 Million - $2.79 Million	169,287 Added 35.93%	640,432 $8.97 Million
Q4 2022 Jan 27, 2023	BUY	$12.5 - $24.78 $879,550 - $1.74 Million	70,364 Added 17.56%	471,145 $6.74 Million
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $506,718 - $747,041	-24,598 Reduced 5.78%	400,781 $10.2 Million
Q2 2022 Aug 12, 2022	BUY	$26.05 - $37.48 $3.34 Million - $4.8 Million	128,150 Added 43.11%	425,379 $12.1 Million
Q1 2022 May 12, 2022	BUY	$24.46 - $40.92 $3.87 Million - $6.48 Million	158,299 Added 113.94%	297,229 $10.5 Million
Q4 2021 Feb 08, 2022	SELL	$35.0 - $45.94 $86,450 - $113,471	-2,470 Reduced 1.75%	138,930 $5.82 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $136,748 - $225,263	3,716 Added 2.7%	141,400 $6.94 Million
Q2 2021 Aug 12, 2021	BUY	$32.46 - $45.0 $1.1 Million - $1.53 Million	33,894 Added 32.66%	137,684 $5.75 Million
Q1 2021 May 05, 2021	BUY	$25.8 - $38.49 $1.08 Million - $1.62 Million	41,976 Added 67.91%	103,790 $3.7 Million
Q4 2020 Feb 12, 2021	BUY	$24.5 - $30.86 $1.51 Million - $1.91 Million	61,814 New	61,814 $1.73 Million

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $687M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.